Inventor · disambiguated record
Els Anna Alice Beirnaert
Also filed as: BEIRNAERT ELS · BEIRNAERT ELS ANNA ALICE
18 granted patents·10 pending applications·265 citations·filing 2002–2022
95Inventor score
Files withABLYNX NV20BEIRNAERT ELS ANNA ALICE4BEIRNAERT ELS2AELIN THERAPEUTICS1KOLKMAN JOOST ALEXANDER1
Top patents by PatentIndex Score
28 records- 0195US9067991B2Nanobodies against tumor necrosis factor-alphaABLYNX NV·Filed 2014·Granted Jun 30, 2015·21 cites·19 claims
- 0295US8629244B2Interleukin-6 receptor binding polypeptidesKOLKMAN JOOST ALEXANDER·Filed 2007·Granted Jan 14, 2014·51 cites·22 claims
- 0395US8188223B2Serum albumin binding proteinsBEIRNAERT ELS·Filed 2006·Granted May 29, 2012·60 cites·18 claims
- 0494US8623361B2Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disordersBEIRNAERT ELS ANNA ALICE·Filed 2008·Granted Jan 7, 2014·25 cites·20 claims
- 0593US8703131B2Nanobodies against tumor necrosis factor-alphaBEIRNAERT ELS ANNA ALICE·Filed 2006·Granted Apr 22, 2014·29 cites·48 claims
- 0692US8962805B2Anti IL-6R polypeptides and compositions thereofABLYNX NV·Filed 2014·Granted Feb 24, 2015·14 cites·19 claims
- 0791US9273150B2Methods of using IL-6R antibodies to block or reduce binding of IL-6 to IL-6RABLYNX NV·Filed 2014·Granted Mar 1, 2016·11 cites·16 claims
- 0891US8748581B2Anti-IL-6R polypeptides and pharmaceutical compositions thereofBEIRNAERT ELS ANNA ALICE·Filed 2010·Granted Jun 10, 2014·15 cites·11 claims
- 0990US9181350B2Nucleic acids encoding IL-6R-binding polypeptidesABLYNX NV·Filed 2014·Granted Nov 10, 2015·10 cites·23 claims
- 1089US9605072B2Nucleic acids that encode interleukin-6 receptor binding polypeptidesABLYNX NV·Filed 2014·Granted Mar 28, 2017·8 cites·42 claims
- 1188US9611326B2Interleukin-6 receptor binding polypeptidesABLYNX NV·Filed 2013·Granted Apr 4, 2017·7 cites·22 claims
- 1287US9617341B2Methods for blocking or reducing binding of interleukin-6 to interleukin-6 receptorABLYNX NV·Filed 2014·Granted Apr 11, 2017·7 cites·34 claims
- 1386US10618966B2Methods for the treatment of interleukin-6 receptor-related diseases and disordersABLYNX NV·Filed 2017·Granted Apr 14, 2020·2 cites·18 claims
- 1484US10392440B2Methods for the preparation of compounds directed against interleukin-6 receptor (IL-6R)ABLYNX NV·Filed 2016·Granted Aug 27, 2019·3 cites·12 claims
- 1581US2023031229A1Nanobodies against tumor necrosis factor-alphaABLYNX NV·Filed 2022·Application pending·0 cites
- 1675US9475877B2Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disordersBEIRNAERT ELS ANNA ALICE·Filed 2009·Granted Oct 25, 2016·1 cites·22 claims
- 1774US9534055B2Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disordersABLYNX NV·Filed 2013·Granted Jan 3, 2017·1 cites·17 claims
- 1870US11472871B2Nanobodies against tumor necrosis factor-alphaABLYNX NV·Filed 2019·Granted Oct 18, 2022·0 cites·6 claims
- 1962US2017342146A1Nanobodies against tumor necrosis factor-alphaABLYNX NV·Filed 2017·Application pending·0 cites
- 2061US11078290B2Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disordersABLYNX NV·Filed 2016·Granted Aug 3, 2021·0 cites·15 claims
- 2157US2017096490A1Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disordersABLYNX NV·Filed 2016·Application pending·0 cites
- 2256US2015353635A1Nanobodies against tumor necrosis factor-alphaABLYNX NV·Filed 2015·Application pending·0 cites
- 2353US2023287046A1Molecules targeting proteinsAELIN THERAPEUTICS·Filed 2021·Application pending·0 cites
- 2452US2011091462A1Novel antigen binding dimer-complexes, methods of making and uses thereofABLYNX NV·Filed 2009·Application pending·0 cites
- 2550US2006034833A1Single domain antibodies directed against interferron-gamma and uses thereforBEIRNAERT ELS·Filed 2003·Application pending·0 cites
- 2648US2010113339A1Serum albumin binding proteins with long half-livesABLYNX NV·Filed 2007·Application pending·0 cites
- 2746US2007269422A1Serum albumin binding proteins with long half-livesABLYNX NV·Filed 2006·Application pending·0 cites
- 2841US2005214857A1Method for displaying loops from immunoglobulin domains in different contextsABLYNX NV·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Els Anna Alice Beirnaert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →